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A B S T R A C T
Here, we report a method to clean cassava plants from viral infections that cause cassava mosaic and brown
streak diseases in Africa. Infected plants of resistant or tolerant varieties from Malawi, Mozambique, Kenya,
Tanzania and Uganda were cleaned in the UK using a combination of tissue culture, chemotherapy and ther-
motherapy. In the ﬁrst cycle of our virus-indexing procedure, we successfully cleaned 27 of the 31 varieties
(87%), and after an additional three cleaning cycles, all plants were virus-free. Virus-free tissue-cultured plants
were shipped back to Africa for distribution to farmers. This ﬁrst cross-boundary eﬀort provides important
lessons for mitigating the two-major cassava viral diseases.
1. Introduction
Cassava (Manihot esculenta Crantz; Euphorbiaceae) is a staple crop
for more than 800 million people in the tropics [1]. The crop is aﬀected
by more than 100 insect and mite species and about 30 cassava diseases
induced by viruses, phytoplasmas, bacteria or fungi [2]. Among the
diseases, cassava mosaic disease (CMD) and cassava brown streak dis-
ease (CBSD) are the most important viral diseases in Africa [3–6].
Epidemics of both diseases have occurred during the last two decades
(sometimes simultaneously), severely aﬀecting cassava production and
threatening the livelihoods of farmers and food security in eastern
African countries [7].
CMD is caused by 11 species of single-stranded DNA viruses be-
longing to the family Geminiviridae, genus Begomovirus, which are
collectively called cassava mosaic begomoviruses or CMBs [4,5]. These
viruses are transmitted by whiteﬂy, Bemisia tabaci Gennadius (family
Aleyrodidae, order Hemiptera), as well as disseminated through the
propagation of infected cuttings [6]. The most obvious symptoms of
CMD include a characteristic mosaic of pale green to yellow chlorotic
areas on leaves, usually accompanied by distortion (Fig. 1). Growth of
susceptible plants infected at the cutting stage is severely stunted and
there is poor development of the tuberous roots, which ultimately re-
sults in low yields [8]. The spread of an unusually severe form of CMD,
the so-called “CMD pandemic”, was ﬁrst recorded in Uganda in the late
1980s and subsequently spread to aﬀect an area greater than 4 million
km2 across 11 countries of East and Central Africa [5,6,8,9]. Since then,
considerable success has been achieved in mitigating the eﬀects of the
CMD pandemic through the multiplication and dissemination of CMD-
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resistant varieties [5]. However, severe CMD continues to spread into
newer areas. Previous estimates of CMD incidences in Africa range from
50% to 60% with estimated annual losses of US $1.2–2.4 billion [8,9].
CBSD is caused by two species of RNA viruses; Cassava brown streak
virus (CBSV) and Ugandan cassava brown streak virus (UCBSV) both of
which belong to the family Potyviridae of the genus Ipomovirus [10–12],
and are collectively referred to as cassava brown streak ipomoviruses,
or CBSIs. Like CMBs, CBSIs are also transmitted by B. tabaci, and spread
by propagating infected cuttings in the ﬁeld [13,14]. The prominent
symptoms of CBSD appear on leaves with varying patterns of leaf
chlorosis that appears in a feathery pattern along the margins of sec-
ondary and tertiary veins, which may coalesce to form chlorotic blot-
ches (Fig. 1) [3,6,15]. There is considerable variation in the expression
of foliar symptoms depending on the cassava variety, the growing
conditions (temperature, rainfall and altitude), the age of the plant, and
the viral species. Some cultivars show marked foliar symptoms but lack
root symptoms or have a delay in the expression of root symptoms (e.g.
in ‘Kiroba’), whereas other cultivars lack foliar symptoms but have af-
fected roots [3,16].
For the last 80 years, CBSD has been endemic in low altitude areas
along the Indian Ocean coast of eastern Africa, from the north-eastern
border of Kenya across the Tanzanian border down as far as the
Zambezi River in Mozambique, and it has been widespread along the
shores of Lake Malawi [3,6,12]. More recently, CBSD was reported in
Uganda, a high altitude area inland from the east African coast, and
subsequently in the neighbouring countries in the Great Lakes region of
East and Central Africa, including Burundi, Rwanda, southern Sudan
and the eastern part of Democratic Republic of Congo [3,4,15]. The
spread into the Great Lakes region is a major concern because CBSD
incidences of up to 100% were recorded and has resulted in rotting of
tuberous roots in virus-sensitive varieties, reducing both the quality and
quantity of tuberous roots available for consumption [3,5]. Recent es-
timates indicate that CBSD causes great economic losses of up to US
$726 million annually to African farmers [17]. The disease has been the
most important cause of food insecurity in the coastal and lake zone
areas of eastern Africa and is considered a serious threat to the entire
cassava-growing belt of Sub-Saharan Africa [7].
CMD has been managed in many pandemic-aﬀected countries
through developing and disseminating resistant varieties, however,
progress managing CBSD has been slower [5,7]. Only a small number of
cassava varieties expressing a range of resistance levels are currently
available in CBSD-aﬀected countries, but even these can be infected
with CBSIs [16,18,19]. Several technologies are being recommended
for controlling CBSD in farmer's ﬁelds including rigorous phytosanita-
tion and treating cassava stems with insecticides to prevent early virus
infections by the vector whiteﬂies. However, using resistant varieties
represents the best solution currently available for CBSD control. Re-
cent ﬁndings in our knowledge about CBSD epidemiology, however,
have provided new opportunities for control [14]. We have recently
shown that whiteﬂies transmit CBSIs poorly and that an isolation
distance of about 100m is suﬃcient to signiﬁcantly minimise the
spread of CBSIs between infected and disease-free plots [14]. These
results provide an indication that phytosanitary measures, such as those
involving the use of virus-free planting material coupled with isolation
from surrounding potential sources of infection, oﬀer excellent poten-
tial for CBSD control. This new knowledge also highlights the value in
establishing and maintaining virus-free stocks of planting material and
using such stocks as the foundation for lower tiers of seed multi-
plication [20].
Using this new knowledge, we developed virus-indexing, tissue-
culture and chemo- and thermo-therapy protocols for cleaning cassava
varieties from virus infections from the ﬁve most aﬀected countries of
eastern and southern Africa (Fig. 2). These protocols have long been
used for generating virus-free plants in several other crop plants in-
cluding the main root and tuber crops of Africa such as cassava, yams
and sweetpotatoes. In a recent study, up to 73% of the yam plants were
conﬁrmed to be free from Yam mosaic virus following tissue culture and
heat therapies, and while the results for other viruses were inconsistent
[21]. Such protocols are also adapted by the regulatory bodies in
Ethiopia and Tanzania for generating certiﬁed seeds of sweetpotatoes
[22]. In Africa and elsewhere, virus-free planting materials have been
developed for several other crops including banana, citrus and cassava
for providing healthy planting material to farmers for increased yields
[20,23,24]. In this paper, we describe the use of such virus-indexing
protocols at a regional level for cleaning cassava from ﬁve eastern and
southern African countries of Kenya, Tanzania, Uganda, Malawi and
Mozambique in the project “Cassava varieties and Clean seed to Combat
CBSD and CMD project (5CP)” for providing virus-free planting mate-
rial to the aﬀected farmers.
2. Materials and methods
The virus cleaning was done in the UK, which was used as a ‘neutral’
location for importing virus-infected cassava plants from Kenya,
Malawi, Mozambique, Tanzania and Uganda. For operational reasons,
the process of cleaning cassava from virus infections and their sub-
sequent returning back to the African institutions was divided into four
key phases, which formed one “cycle” of the virus-indexing procedure
(Fig. 2). Each cycle contained the following four phases:
Phase I: Establishing cassava lines in quarantine glasshouses and
scoring for disease incidences.
Phase II: Testing mother plants for viruses by polymerase chain
reaction (PCR).
Phase III: Micro-propagation, chemo- and thermo-therapies.
Phase IV: Shipping and hardening tissue-cultured virus-free plants.
2.1. Phase I: establishing cassava lines and scoring for disease incidences
Between 10 and 24 stem cuttings each of ﬁve to seven cassava
varieties were collected from farmer's ﬁelds or research trials from each
Fig. 1. Typical symptoms of CMD (left) and CBSD (right) on cassava leaves.
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of ﬁve countries (Kenya, Malawi, Mozambique, Tanzania and Uganda)
and shipped to the Natural Resources Institute (NRI) in the UK in
July–August 2012 (Table 1). These cassava varieties represented the
varieties that were most promising for resistance to CMD, CBSD or both
diseases in those countries at that time. The cassava varieties were
classiﬁed into resistant, tolerant or susceptible to the diseases based on
their reaction to each disease as described previously [5,9,16,18].
These also include some farmer-preferred varieties and susceptible
controls for comparison purposes. Upon arrival in the UK, the cuttings
(each 12–15 cm in length) of all 31 genotypes were treated with a so-
lution of the systemic insecticide Intercept (ICL Ipswich, UK) (a.i. imi-
dacloprid 0.5 g per litre of water) for 30min to kill scales, mealybugs,
mites and any other pests prior to planting in a mixture of soil and
compost (John Innes No. 2; Fargro Ltd., Arundel, UK) in small plastic
pots (15 cm diameter). Each plant was labelled with a unique identiﬁ-
cation number and grown in an insect-free quarantine glasshouse at
25 ± 5 °C, 50%–60% relative humidity (RH) and L14:D10 (light:dark)
hours for three months. Plants showing CMD and CBSD symptoms were
recorded (Fig. 1) every week and immediately separated from the non-
symptomatic plants. Non-symptomatic plants were conﬁrmed to be
virus-free by PCR in Phase II of the protocol. Symptomatic plants were
either discarded or kept for cleaning from virus infections in a future
cycle of cleaning.
Fig. 2. Schematic diagram of one cycle of cleaning and indexing to generate virus-free cassava plants. Each cycle is divided into four phases.
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2.2. Phase II: testing mother plants for viruses by PCR
2.2.1. Total nucleic acid extraction for virus-indexing
Leaf samples were collected from the top, middle and bottom part of
the plant and total nucleic acid was extracted from all non-symptomatic
plants using a modiﬁed cetyl trimethylammonium bromide (CTAB)
method [25–28]. The optimised protocol was as follows: First, the
CTAB extraction buﬀer (2% (w/v) CTAB, 1.4M NaCl, 0.2% (v/v) 2-
mercaptoethanol, 20mM EDTA, 100mM Tris-HCl, pH 8.0) was pre-
heated to 60 °C for 10min. Mercaptoethanol was added fresh to the
buﬀer. Approximately 100mg of fresh plant leaf tissue was placed into
a thick-gauge plastic bag (10× 15 cm) and the tissue was ground ﬁnely
using a ball-bearing grinder (Qiagen Ltd. Dorset UK). Each 100mg of
ground plant tissue was then mixed with 1mL of CTAB extraction
buﬀer. About 750 μL of the sample was poured into a 1.5 mL centrifuge
tube and heated at 60 °C for 30min. Next, the samples were mixed with
an equal volume (750 μL) of phenol:chloroform:isoamylalcohol
(25:24:1) in a fume hood and centrifuged at 12,281 relative centrifugal
force (g) for 10min. Only the aqueous phase was transferred into a new
1.5 mL centrifuge tube. To precipitate the DNA, we added 300 μL of
cold (−20 °C) isopropanol and incubated at −20 °C for at least 1 h.
Samples were then centrifuged at 12,281 g at 4 °C for 10min. The su-
pernatant was discarded, and the pellet was washed with 0.5ml of 70%
ethanol, vortexed and centrifuged for 5min at 12,281 g. Then the
ethanol was removed and the pellet was vacuum-dried for 5min. The
dried pellet was suspended in 100 μL 1x TE buﬀer and stored at−20 °C.
The extracts were diluted 1:10 fold in sterilised deionised water (SDW)
before using them in PCR and reverse-transcriptase PCR (RT-PCR) for
virus detection (Fig. 3).
2.2.2. cDNA synthesis
Synthesis of cDNA was done using ImProm-II™ Reverse
Transcriptase kit (Promega, Southampton, UK) following the manu-
facturer's instructions. Brieﬂy, we prepared 5 μL Master Mix I per
sample containing 1 μL each of SDW, Oligo-dT primer and 3 μL of RNA
template. We incubated the mix at 70 °C for 5min and immediately
chilled on ice for 2min. Next, we prepared 15 μL Master Mix II per
sample containing 7.5 μL SDW, 4.0 μL ImProm-IITM 5X reaction buﬀer,
2.0 μL 25mM MgCl2, 1.0 μL 2.5mM dNTPs and 0.5 μL ImProm-II
Reverse Transcriptase, and gently mixed in a vortexer for 3–5 s. Next,
we added 15 μL Master Mix II into 5 μL Master Mix I making up a total
volume of 20 μL per reaction. The reaction mixture was incubated at
25 °C for 5min for primer annealing, at 40 °C for 60min for cDNA
synthesis, and ﬁnally at 70 °C for 15min for inactivation of the ImPro-
II™ Reverse Transcriptase. The resulting cDNA samples were stored at
−20 °C until further analysis.
2.2.3. Choice of PCR tests
A range of tests are available for diagnosing CMBs and CBSIs, in-
cluding endpoint PCR and RT-PCR for detecting one virus at a time, as
well as duplex and multiplex reactions that can detect two or more
viruses in a single reaction [25,26, 29, 35]. Several real-time PCR assays
are also available for CMBs and CBSIs [28,30; 34]. Tests were chosen
based on the sensitivity required and the range of viruses to be tested,
as well as personal preference, expertise and the facilities available. In
this study, to detect CMBs (ACMV, EACMV and EACMV-Ug) and CBSIs
we initially used the protocols published in Ref. [25] (Fig. 3) and
subsequently [28]. A summary of the viruses detected, primers used
and PCR conditions is in Tables 2–3.
2.3. Phase III: micro-propagation, thermo- and chemotherapies
2.3.1. Preparing MS medium for cassava nodal-bud culture
The protocol used to make 1 L of tissue-culture media (∼125 tubes
of 8mL each) was as follows: ﬁrst, we added 2.2 g Murashige and Skoog
(MS) medium to a 2 L capacity beaker, then we added 20 g sucrose and
∼950mL of deionised water. A magnetic stirrer was used to mix the
Table 1
The 31 cassava varieties obtained from ﬁve eastern and southern African
countries and cleaned of viral infections in the UK.
Country of origin Variety name Reaction to diseases No. of stems
imported and
planted in the
UK
CMD CBSD
Kenya F10-30-R2 Tolerant Tolerant 20
F19-NL Tolerant Tolerant 23
LMI/2008/363 Tolerant Tolerant 22
Kibandameno Susceptible Susceptible 20
Shibe Tolerant Tolerant 21
Tajirika Tolerant Tolerant 20
Malawi CH05/203 Tolerant Tolerant 24
Kalawe Tolerant Tolerant 20
Mbundumali Susceptible Susceptible 21
Sangoja Tolerant Tolerant 20
Sauti Tolerant Tolerant 22
Yizaso Tolerant Tolerant 20
Mozambique Coliacanana Susceptible Tolerant 21
Eyope Tolerant Tolerant 22
Nziva Susceptible Tolerant 22
Okhumelela Tolerant Tolerant 21
Orera Susceptible Tolerant 22
Tanzania KBH2002/066 Tolerant Tolerant 21
KBH2006/026 Tolerant Tolerant 21
Albert Resistant Susceptible Previous
collection
Kiroba Susceptible Tolerant Previous
collection
Kizimbani Tolerant Tolerant 21
Mkombozi Resistant Susceptible 17
Mkumba Susceptible Tolerant 21
Pwani Tolerant Tolerant 21
Uganda TZ130 Resistant Tolerant 14
NASE1 Resistant Tolerant 14
NASE3 Tolerant Tolerant 12
NASE14 Resistant Tolerant 13
NASE18 Resistant Tolerant 10
TME204 Resistant Susceptible 13
Fig. 3. Duplex RT-PCR results (A) CMBs and CBSIs, (B) and UCBSV and CBSV.
The New England Biolab's 1 Kb and 500 bp markers are used in (A) and (B),
respectively. Samples ampliﬁed were mixed infections with respective viruses
identiﬁed on the pictures.
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solution. Next, we added growth regulators (8 mL of NAA/L at conc.
27 μM) and Plant Preservation Mixture (PPM, Sigma-Aldrich, Dorset,
UK) at 0.2–0.25 v/v % of PPM. The pH was adjusted to 5.7–5.8 using
NaOH and/or HCl buﬀer solutions (buﬀer solutions should be 10% and
1% for ﬁne adjustments). We then added deionised water to make so-
lutions up to 1 L. Next, we added 2 g phytagel (Sigma-Aldrich, Dorset,
UK) and 25mg Ribavrin (ﬁnal concentration 0.1 mM). Addition of
Ribavrin was only required for media used for chemotherapy of virus-
infected plant material. Each solution was mixed using a magnetic
stirrer to ensure an even distribution of undissolved gelling agent while
the media was pipetted into culture tubes. We added 8mL media into
clean glass tubes (e.g. Timstar, borosilicate glass, 100×25mm) and
sealed them with lids. The tubes were then wrapped in greaseproof
paper and/or aluminium foil (minimum of two layers) and autoclaved
at 121 °C for 15min. Tubes were then dried in an oven for 4 h at 60 °C
and ﬁnally cooled to ambient temperature before use.
2.3.2. Surface sterilisation of explants
At least 20 cuttings from each of 31 genotypes were collected from
the ﬁve African countries. At the time of collection, the top green parts
of each plant's stem were cleaned separately, all leaves were removed
and the stems were placed in plastic, labelled bags. Upon arrival in the
UK, the stems (explants) were trimmed to a suitable size (usually up to
5 cm) that contained at least one nodal bud. The explants were then
transferred into separate glass jars and washed 3 times in running tap
water. The explants were then immersed in 70% ethanol for 3–5 s be-
fore the ethanol was poured out of the jars and replaced with a ster-
ilisation solution (5% v/v sodium hypochlorite and 0.1mL/L of Tween
20) that almost covered the explants. The jars were then placed on a
shaker and mixed vigorously on an orbital shaker at 100 g for
20–30min. After shaking, the explants were rinsed with SDW under
aseptic conditions in a laminar ﬂow cabinet (LFC). Explants were rinsed
three to four times until no foam was left in the bottles. These sterile
explants were used for seeding into tissue-culture media.
2.3.3. Seeding nodal buds into MS media
The protocol for seeding nodal buds into MS media was done inside
the LFC. Prior to beginning work with the explants, the UV lamp was
turned on for 10min, the laminar ﬂow was turned on, and the working
surfaces were decontaminated with 100% ethanol. Explants were ex-
cised in sterile petri dishes using sterile knives and sterile forceps. We
retained only 2–3mm of each node bud by removing excess tissue
around the bud (Fig. 4A). The node bud was then transferred into MS
media using forceps ensuring that the node bud was facing upwards
(Fig. 4B). The cap of the tube was closed immediately and all tubes from
a single plant were labelled before seeding the next plant (Fig. 4C).
Work was done near a Bunsen ﬂame to further reduce the risk of con-
taminating organisms. Seeded tubes were transferred into a plant
growth chamber (SLS Ltd., Wilford, UK) that was maintained at 35 °C,
50%–60% RH, and 14L:10D for heat treatment. Plants were maintained
at these conditions for two weeks. Note: this step was only performed
for virus-infected material receiving thermotherapy. Plants were then
transferred to 25 °C growth rooms for the next 10 weeks before either
being shipped back to the project's African partners or being hardened
by planting into soil media for further growth in the UK.
2.4. Phase IV: hardening and establishing tissue-culture cassava plants in
the soil
2.4.1. Transplanting and hardening tissue-culture plants
Plantlets were removed from the glass tubes, the media was gently
washed oﬀ using tap water or SDW. The oldest and middle leaves were
removed using sharp scissors, retaining only three or four developing
leaves at the top of the plant. Further, to prevent fungal growth on any
traces of leftover media, the plantlets were rinsed in the fungicide so-
lution Dithane, 6 g/L (Mancozeb 80% a.i.) (ICL Ipswich, UK) for 10min.
Plantlets were placed into small pots (10 cm diameter) with compost
and soil in 1:1 proportion and the pots were placed onto a propagator
tray and watered just enough to soak the soil mixture (Fig. 5). After
watering, the tray was immediately covered with a transparent lid that
had been sprayed with water to raise the humidity. Lids were kept
closed for a minimum of two weeks to allow the plants to develop new
roots and leaves. Conditions were maintained at 30 ± 5 °C, 50–60%
RH, 14L:10D. After two weeks, the vents in the lids were opened for one
week and then we started lifting the lids incrementally using spacers
between the lid and the tray. At the end of four weeks, the lids were
Table 2
Primers used for detecting CMBs and CBSIs in uniplex, duplex and multiplex RT-PCR assays.
Primer name Primer sequence (5′–3′) Targeta Reference
Primers used for amplifying CMBs
Deng A TAATATTACCKGWKGVCCSC Begomovirus [31]
Deng B TGGACYTTRCAWGGBCCTTCACA Begomovirus [31]
CMBRep/F CRTCAATGACGTTGTACCA ACMV & EACMV [29]
CMBCP/F GKCGAAGCGACCAGGAGAT ACMV & EACMV-Ug [29]
ACMVCP/R CCCTGYCTCCTGATGATTATA ACMV [29]
EACMV-UG/R CGCCTAAGCAAGGAATGGCGT EACMV-Ug [25]
EACMVRep/R GGTTTGCAGAGAACTACATC EACMV [29]
Primers used for amplifying CBSIs
RT-PCR
CBSVF3 GGARCCRATGTAYAAATTTGC CBSIs [25]
CBSVR3 AGGAGCWGCTARWGCAAA CBSIs [25]
RT-qPCR
CBSVR4
+ CBSVF3
GCWGCTTTTATYACAAAMGC CBSIs [28]
Primers used for amplifying CBSV and UCBSV individually
CBSVF2 GGRCCATACATYAARTGGTT CBSIs [25]
CBSVR7 CCCTTTGCAAARCTRAAATARC CBSV [25]
CBSVR8 CCATTRTCTYTCCAMADCTTC UCBSV [25]
Primers used for amplifying cassava housekeeping genes
RubiscoLF CTTTCCAAGGCCCGCCTCA RubiscoL [32]
RubiscoLR CATCATCTTTGGTAAAATCAAGTCCA RubiscoL [29]
L2F TGGTGTTGCCATGAACCCTGTAGA Ribosomal protein (L2) [33]
L2R CGACCAGTCCTCCTTGCAGC Ribosomal protein (L2) [33]
a ACMV – African cassava mosaic virus; EACMV – East African cassava mosaic virus; EACMV-Ug – East African cassava mosaic virus-Uganda; CBSIs – cassava
brown streak ipomoviruses; CBSV – Cassava brown streak virus; UCBSV – Ugandan Cassava brown streak virus.
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Table 3
Primers and PCR conditions used for the eﬃcient detection of targeted viruses.
Target virusa Primer name and combinations Primer concentration (μM) Annealing temperature (ºC) Expected PCR product (bp)
Uniplex PCR
CBSIs CBSVF3
CBSVR3
0.4
0.4
52 283
CBSIs CBSVF5
CBSVR3
0.4
0.4
52 520
CBSV CBSVF2
CBSVR7
0.4
0.4
52 345
UCBSV CBSVF2
CBSVR8
0.4
0.4
52 441
CMBs Deng A
Deng B
0.6
0.6
52 520
ACMV CMBRep/F
ACMVRep/R
0.4
0.4
52 368
ACMV CMBCP/F
ACMVCP/R
0.4
0.4
52 650
EACMV CMBRep/F
EACMVRep/R
0.4
0.4
52 524
EACMV-UG CMBCP/F
EACMV-UG/R
0.4
0.4
52 1000
Duplex and multiplex PCR
CBSIs + CMBs CBSVF3
CBSVR3
Deng A
Deng B
0.4
0.4
0.6
0.6
52 283
520
CBSV + UCBSV CBSVF2
CBSVR7
CBSVR8
0.4
0.1
0.4
50 345
441
CBSIs + EACMV CBSVF3
CBSVR3
CMBRepF
EACMVRep/R
0.4
0.4
0.4
0.4
52 283
524
CBSIs + ACMV + EACMV-Ug CBSVF3
CBSVR3
CMBCP/F
ACMVCP/R
EACMV-UG/R
0.4
0.4
0.4
0.4
0.4
52 230
650
1000
Real-time PCR
CBSIs CBSVF3 CBSVR4 0.7 68 130
Ribulose biphosphate carboxylase oxygenase gene RubiscoLF
RubiscoLR
0.7 68 171
Ribosomal protein (L2) L2F
L2R
0.7 68 135
a ACMV – African cassava mosaic virus; EACMV – East African cassava mosaic virus; EACMV-Ug – East African cassava mosaic virus-Uganda; CBSIs – cassava brown
streak ipomoviruses; CMBs – cassava mosaic begomoviruses; CBSV – Cassava brown streak virus; UCBSV – Ugandan Cassava brown streak virus.
Fig. 4. (A) Sterilisation and seeding the media with
cassava nodes. Surface-sterilised cassava explants in
the laminar ﬂow ready for rinsing with SDW. (AB)
Cassava node buds trimmed and ready for transfer-
ring into the culture medium. (C) Transferring nodes
into the culture medium. (D). Media tubes with cas-
sava node buds ready for labelling and incubation.
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removed completely, and we applied NPK fertiliser containing Mg
(ratio of 30:10:10:2) and other trace elements (10 g dissolved in 10 L
water) (Fargro Ltd., Arundel, UK). Plants were grown for an additional
four weeks and then hardened by reducing the amount water provided
without allowing plants to dry out completely or shed leaves. Such
hardened plants can be ready to transplant into the soil media.
2.4.2. Accountability and traceability of virus-cleaned plants
We designed a full traceability system that was set up to track each
stem cutting from its arrival at the quarantine facility at NRI, through
the micro-propagation and virus-indexing procedures, to the shipment
of clean material back the partner organisations in East Africa (i.e.
Phases I–IV). A well-designed traceability system that can track plant
material through the processing phases to the partner organisations in
Africa is essential. Such a system provides a control mechanism. If any
plant material was later found to contain a virus, the traceability system
could identify other potentially infected stock, thus limiting viral spread
(Fig. 6).
There were two parts to the traceability system; the ﬁrst was a re-
cord of all plant material. We used Microsoft Excel 2010 to keep a di-
gital record of all the plant material in this project. A digital database is
highly suitable and desirable, however a paper-based system could also
be used. The second part was a labelling system that ensured all plant
material, plants, and plantlets in the glasshouses and tissue-culture fa-
cilities carried a unique identifying code (UIC) (Fig. 6) that linked to the
database. Each stem cutting, plant, and plantlet that was propagated
had its own entry in the spreadsheet. We used a simple sequential UIC,
wherein each generation of propagated or micro-propagated plants
gained an additional digit. For example, for a plant showing the label
“Mal 5.12.2.4” (see Fig. 6), “Mal” indicates a variety from Malawi, “5”
indicates the code name given for the variety, “12” indicates a plant
replicate of that variety, “2” indicates the node number on the plant
(e.g. “2” would be the second node from the top of the plant, a location
that is more likely to be virus-free), and “4” indicates the node number
Fig. 5. Transplanting tissue-cultured cassava plants into soil and their growth. (A) Easing the plantlet from the culture tube and (B) gently removing as much media
gel as possible. (C) Rinsing any remaining gel in warm water (∼25 °C). (D) A plant being transplanted and (E) transplanted plants under propagator lid.
Fig. 6. An example of the plant-labelling system using unique identiﬁcation codes (UIC) at each stage of the plant multiplication process.
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after the ﬁrst sub-culturing from the previous plant. The spreadsheet
was setup such that each row (entry) represented a single bud node
from a plant that had been propagated, while the columns contained
data on various aspects of that bud node and its history including the
UIC, country of origin, cutting number, varietal common name, virus
assessments (visual and PCR based), infection status, location (within
glasshouse or incubator), date of tissue culture, number of nodes micro-
propagated, shipping date, and destination. For each entry, additional
columns were added to record details of thermo- and chemotherapies
and their outcomes, number of nodes that were tissue-cultured, results
of repeated PCR tests (used to conﬁrm previous results prior to ship-
ping), dates plantlets were hardened, dates plants were transferred to
the glasshouses, or anything else pertinent to the work. The “Pivot
Table” function of Excel was used to quickly generate summaries of the
data and track overall progress.
We used ‘mail merge’ function to link between an Excel spreadsheet
and a Word document. A template for labels was set up in a Word
document, wherein each label included all the relevant ﬁelds (e.g. UIC,
date, location). The ‘mail merge’ allows a linked spreadsheet to be ﬁl-
tered by speciﬁc ﬁelds, and then automatically generates the data into
the relevant ﬁelds for each label within the Word document. We used
‘mail merge’ to automatically generate sticky labels for the micro-pro-
pagation tubes, storage and shipping containers, thus minimising the
potential for human error in labelling. A label printer (LabelStation Pro
200, Advanced Labelling Ltd., Dorset, UK) and the LabelStation soft-
ware were used to generate the tags and labels for plants in the glass-
house. Similar to Microsoft ‘Mail Merge’, the LabelStation software was
linked to the Excel spreadsheet. Again, a label template was set up to
contain the relevant ﬁelds. The link between the Excel spreadsheet and
the LabelStation software allowed for data ﬁltering, enabling us to
generate plant tags for speciﬁc batches of plants with the correct UIC
and other relevant information.
3. Results
3.1. Phase I: establishing cassava lines and scoring disease incidences
Between 7 and 21 stem cuttings from 31 cassava varieties were
imported from Kenya, Malawi, Mozambique, Tanzania and Uganda
(Table 1), which accounted for a total of 487 plants. These were grown
in the NRI's quarantine glasshouse in the UK and observed for typical
CMD and CBSD symptoms (Fig. 1) at monthly intervals for three
months. Of these plants, 191 (39.2%) showed disease symptoms within
three months and the remaining 296 were symptoms-free (Table 4). Of
the 191 diseased plants, the proportion of CMD and CBSD varied; 20
were infected with CMD (10.4%) and 171 with CBSD (89.5%). The
incidence of CBSD was highest for the three varieties F19-NL, Ki-
bandameno and NASE14 (100% for all three varieties) but three other
varieties, Colicanana, Orera and KBH 2002/066, were virus-free. In-
cidences of CMD were low on all varieties except NASE 1, which had
the highest incidence (100%, Table 4). Following disease assessment,
most diseased plants were destroyed when suﬃcient number of symp-
tomless plants were available for PCR testing (see below). In cases
where all plants were infected with one or both viruses, at least ﬁve
plants were kept for subsequent virus cleaning and indexing in Phase II.
3.2. Phase II: testing mother plants for viruses by PCR
We used a combination of diagnostic methods [25,28] to test plants
for viral infections. A total 221 symptomless cassava plants were tested
by PCR for CBSIs and CMBs. Of these, 190 (85.9%) were conﬁrmed to
be completely virus-free (Table 5). The remaining 31 (14.0%) were
positive for at least one of the four viruses tested (ACMV, EACMV,
EACMV-Ug and CBSIs); these plants were considered symptomless
carriers. Plants showing even a faint band on gel electrophoresis of PCR
products for any of the four viruses were considered infected. Virus
testing by PCR and RT-PCR was therefore essential for eliminating
symptomless carriers of viruses. Symptomless carriers were either dis-
carded when suﬃcient clean plants were available or used in Phase III
for cleaning from virus infections. In summary, one or more plants of
the 27 of the 31 cassava varieties were found to be free from CMBs and
CBSIs after scoring for disease symptoms in Phase I and virus testing in
Phase II (Table 4). All plants of the remaining four varieties, F19-NL,
Kibandameno, NASE 1 and NASE 14, were still infected with viruses.
Diseased and virus-free plants were propagated separately in Phase III.
3.3. Phase III: micro-propagation, therapy treatments and repeat testing for
viruses
Plants free of CMD and CBSD symptoms and conﬁrmed to be free of
viruses by PCR tests were used for further propagation and multi-
plication by tissue culture. About 100 node buds were planted in tissue
culture media, of which 80–90 healthy plantlets with robust root and
shoot growth were obtained for each of the 27 varieties. The remaining
plantlets either had poor root/shoot growth or were contaminated with
fungi and bacteria (usually< 10%). The healthy plantlets were grown
in the tissue culture media for a minimum of four weeks. A second
round of virus testing was done on these plantlets and conﬁrmed to be
virus-free. Such plantlets were certiﬁed to be free from the infections of
CMBs and CBSIs and shipped to the project partner GTIL in Kenya for
further propagation and subsequent distribution to project partners.
Of the 31 cassava varieties, four (F19-NL, Kibandameno, NASE 1
and NASE 14) were still infected with viruses at the end of Phase II.
These were propagated separately by tissue culture and subjected to
thermo- and chemotherapy treatments. About 50 plantlets of each
variety were grown in tissue-culture media for six weeks, and instead of
shipping them to Kenya for further propagation, these plants were
planted back into soil and compost at the NRI quarantine glasshouses
for plant growth, surveillance for disease symptoms and subsequent
Table 4
CMD and CBSD incidences on cassava varieties three months after planting in
the NRI glasshouse in the UK.
Country of origin Variety No. of
CMD/
total
plants
% CMD
incidence
No. of
CBSD/
total
plants
% CBSD
incidence
Kenya F10-30-R2 0/13 0.0 1/13 7.7
F19-NL 0/17 0.0 17/17 100
LM1/2008/363 0/11 0.0 6/11 54.5
Kibandameno 0/13 0.0 13/13 100
Shibe 0/21 0.0 4/21 19.0
Tajirika 0/19 0.0 2/19 10.5
Malawi CHO5/203 1/7 14.3 2/7 28.6
Kalawe 0/20 0.0 1/20 5.0
Mbundumali 0/21 0.0 7/21 33.3
Sagonja 1/19 5.3 10/19 52.6
Sauti 1/20 5.0 2/20 10
Yizaso 0/18 0.0 9/18 50.0
Mozambique Colicanana 0/21 0.0 0/21 0.0
Eyope 1/22 4.6 2/22 9.1
Nziva 1/22 4.6 3/22 13.6
Oekhumelela 1/21 4.8 1/21 4.8
Orera 0/21 0.0 0/21 0.0
Tanzania KBH 2002/066 0/17 0.0 0/17 0.0
KBH 2006/26 1/20 5.0 16/20 80.0
Kizimbani 0/17 0.0 7/17 41.2
Mkumba 0/19 0.0 10/19 52.6
Pwani 0/21 0.0 18/21 85.7
Uganda TZ 130 0/14 0.0 9/14 64.3
NASE1 12/12 100 3/12 25.0
NASE3 1/12 4.8 4/12 19.0
NASE14 0/13 0.0 13/13 100
NASE18 0/9 0.0 4/9 44.4
TME 204 1/10 10.0 1/10 10.0
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virus testing. This constituted the beginning of a second cycle of virus
indexing protocols. Similar to Cycle 1, plants were grown for three
months and the entire process (scoring for disease symptoms, PCR
testing, tissue culturing, and therapy treatments) was repeated for these
varieties in the second cycle. However, results from the second cycle
were disappointing as none of the plants from these varieties were
virus-free at the end of Cycle 2, although the severity of CBSD symp-
toms was signiﬁcantly lower compared to initially ﬁeld-collected
plants. We speculate that the lower severity in symptoms was the result
of reduced viral load in the tissue-cultured plants because of thermo-
and chemo-therapy treatments. A third cycle of virus indexing proce-
dures was started on the four varieties by repeating the entire process of
growing plants in the quarantine glasshouse for three months, scoring
for disease symptoms, PCR testing, tissue culturing and therapy treat-
ments. Fortunately, these plants were found to be free of CMBs and
CBSIs at the end of the third cycle of cleaning, and these were certiﬁed
to be virus-free and shipped to GTIL Kenya for further multiplication
and distribution [20].
3.4. Phase IV: shipping and hardening tissue-cultured virus-free plants
Obtaining an import permit from the Kenya Plant Health
Inspectorate Services (KEPHIS) and a phytosanitary certiﬁcate from the
UK Department for Environment, Food and Rural Aﬀairs (DEFRA) was a
prerequisite for shipping cassava plants back to Kenya. DEFRA requires
submission of a disease diagnostic report based on the conditions laid
out in the KEPHIS import permit. The conditions included testing plants
for infections by CMBs and CBSIs using PCR/RT-PCR and conﬁrming
them to be free of viruses, as well as cleaned of any visible con-
taminations. Meeting these conditions was an easy task using the pro-
tocol described herein; we had previously tested for CMBs and CBSIs
twice (once on mother plants and again on tissue-cultured plants) and
removed all contaminated plants from inspections. This allowed us to
obtain the DEFRA phytosanitary certiﬁcate easily for shipping the
plants.
For shipping, the glass tubes containing the tissue-culture plantlets
were placed into plastic tube racks and packed into large sturdy
cardboard boxes with suﬃcient padding around the racks to minimise
the impact of handling during transportation. The tissue-culture media
used for plantlets to be shipped had a slightly higher concentration of
phytagel (2.2 g/L instead of the normal 2 g/L), which provided a stur-
dier medium that reduced the chances of plantlet damage during
transit. Both import permit and phytosanitary certiﬁcates were in-
cluded into the courier parcel to facilitate clearance at Kenya's customs
department. Approximately 3000 certiﬁed cassava plantlets (about 100
for each variety) were shipped to GTIL Kenya. We communicated with
the GTIL prior to shipping plants to minimise delays in customs clear-
ance. Tissue-cultured cassava plantlets can survive in the dark condi-
tions of a parcel pack for up to a week, but any further delays will
negatively aﬀect their survival. It is advisable to open the parcel im-
mediately upon receiving it and put the plantlets under bright light in a
tissue-culture room or expose to natural light under a shade. Plants
should be allowed to acclimatise to the new conditions for about a week
before opening the tubes to begin the hardening process. In our project,
these steps were done seamlessly because our partner that received the
plants, GTIL in Kenya, has the requisite experience working with tissue-
cultured plants. GTIL multiplied these cleaned plants and about 2000
plantlets were redistributed to partners in Kenya, Malawi, Mozambique,
Tanzania and Uganda [20].
4. Discussion
This study contributed to the ﬁrst regional attempt in eastern and
southern Africa to control the two major viral diseases of cassava by
exchanging the best virus-resistant/tolerant varieties between the worst
aﬀected countries. The cassava varieties were sent to the UK as a
‘neutral venue’ for cleaning 31 cassava varieties from infections of
CMBs and CBSIs by virus indexing, tissue culture and therapy treat-
ments. They were cleaned successfully and shipped back to the African
partners for multiplication and subsequent distribution to farmers [20].
The process of cleaning indeed started while collecting cassava stem
cuttings in farmer's ﬁelds in the African countries. Care was taken to
select cuttings from plants free of pest and disease symptoms to facil-
itate easier cultivation in the quarantine glasshouse in the UK. Scale
Table 5
A summary of the PCR testing of symptomless cassava varieties at the ﬁrst cycle of the virus indexing procedures in the project 5CP.
Country of origin Variety No. virus-free plants/total
symptomless tested (%)
No. +ve for CBSIs/
total tested (%)
No. +ve for ACMV/
total tested (%)
No. +ve for EACMV/
total tested (%)
No. +ve for EACMV-Ug/
total testeda
Kenya F10-30-R2 12/12 0/12 0/12 0/12 0/12
F19-NL 0/1 1/1 0/1 0/1 0/1
LMI/2008/363 6/6 0/6 0/6 0/6 0/6
Shibe 11/15 (73.3) 3/15 (20.0) 1/15 (6.7) 0/15 0/15
Tajirika 10/14 (71.4) 4/14 (28.6) 0/14 0/14 0/14
Malawi CHO5/203 5/6 (83.3) 0/6 1/6 (16.7) 0/6 0/6
Kalawe 12/12 0/12 0/12 0/12 0/12
Mbundumali 9/9 0/9 0/9 0/9 0/9
Sagonja 8/8 0/8 0/8 0/8 0/8
Sauti 10/11 (90.9) 1/11 (9.1) 0/11 0/11 0/11
Yizaso 7/7 0/7 0/7 0/7 0/7
Mozambique Colicanana 11/12 (91.6) 1/12 (8.3) 0/12 0/12 0/12
Eyope 11/11 0/11 0/11 0/11 0/11
Nziva 10/10 0/10 0/10 0/10 0/10
Oekhumelela 10/10 0/10 0/10 0/10 0/10
Orera 9/9 0/9 0/9 0/9 0/9
Tanzania KBH 2006/26 3/3 0/3 0/3 0/3 0/3
KBH 2002/066 9/12 (75.0) 2/12 (16.7) 1/12 (8.3) 1/12 (8.3) 1/12 (8.3)
Kizimbani 9/14 (64.2) 5/14 (35.7) 0/14 0/14 0/14
Mkumba 8/9 (88.8) 1/9 (11.1) 0/9 0/9 0/9
Pwani 0/2 2/2 0/2 0/2 0/2
Uganda TZ130 3/5 (60.0) 1/5 (20.0) 1/5 (20.0) 0/5 0/5
NASE1 7/8 (87.5) 0/8 1/8 (12.5) 0/8 0/8
NASE18 3/5 (60.0) 1/5 (20.0) 1/5 (20.0) 0/5 0/5
TME 204 6/7 (85.7) 1/7 (14.3) 0/7 0/7 0/7
a ACMV – African cassava mosaic virus; EACMV – East African cassava mosaic virus; EACMV-Ug – East African cassava mosaic virus-Uganda; CBSIs – cassava brown
streak ipomoviruses.
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insects, mealybugs and mites would add additional challenges during
viral cleaning because these pests are diﬃcult to control in the con-
tained environment of a glasshouse. Whenever possible, we also se-
lected plants free of viral symptoms because starting with plants that
have low or no viral load greatly reduces the time and eﬀort required to
eliminate viruses. In our experience, susceptible plants of the four
cassava varieties with severe viral infections required 2–3 cycles of
therapy and tissue culturing and this took up to two years (Fig. 1).
Tolerant and resistant plants were cleaned in the ﬁrst cycle, which took
only about 8–10 months. Cleaning of vegetatively-propagated crops like
cassava in this study and bananas, potatoes, sweetpotatoes, sugarcane
and other crops by others has been done before [21,22,24]. However,
cleaning and germplasm exchange at regional level is the ﬁrst of its kind
to our knowledge for any vegetatively-propagated crop and sets an
example to follow for other crops for better disease control, improved
yields and food securities. Use of insecticides have been increasingly
recommended for controlling the whiteﬂy vector of CMBs and CBSIs
[5,7]. Our virus-free cassava varieties that have high levels of tolerance
to CMD and CBSD can therefore be part of an integrated program for
controlling both whiteﬂies and viral diseases.
A critical part of our method for virus indexing and cleaning was
careful monitoring and surveillance of each plant. Plants were grown
for three months and scored for disease symptoms every month.
Surveillance of each plant throughout the three-month growth period
was critical because some tolerant varieties have longer incubation
periods before the expression of viral symptoms. A three-month growth
period thus minimises false positives (plants incorrectly identiﬁed as
virus-free) and reduces the number of plants that need to be conﬁrmed
virus-free by PCR and subsequent tissue culturing in Phase II [23]. A
critical examination of symptoms therefore saves both time and re-
sources while minimising the multiplication of virus-infected plants. It
is important to note, however, that although CMD symptoms are easily
recognisable, scoring for CBSD was done by an experienced researcher
based on detailed description of symptoms and how they are aﬀected by
environments [3,16].
The PCR tests were chosen by the sensitivity required based on the
source of the sampled material. For example, the recent real-time PCR
Taqman assays [28] which were up to 300% more sensitive were pre-
ferred over the end-point PCR methods [25,26] when they became
available in our laboratories. We found that collecting leaf samples
from three parts of the plant (top, middle and bottom) and pooling
them together during sample preparation greatly increased the chance
of virus detection because viruses that are restricted to one part of the
plant are more likely to be detected using this sampling method. We
adopted this sampling method for testing all plants in this study [28].
Another critical aspect of this work was adapting a ‘zero tolerance’
policy for virus testing to prevent inadvertent virus introduction and
movement between the aﬀected countries. To prevent this, all plants
were tested twice by PCR for CMBs and CBSIs during the cleaning
process. The ﬁrst testing was done before tissue culturing of the mother
plants and thus prevented multiplication of infected material at the very
beginning of the process. The second testing was done after the tissue
culturing was done and before the plants were shipped out to Africa to
make sure plants were indeed virus-free. Unlike leaf collection from the
mother plants in the glasshouse for virus testing, collecting re-
presentative leaf samples from the tissue-culture plants that were grown
in small glass tubes (2.5 cm diameter) was diﬃcult because of their
small size. We used sharp forceps to collect 2–3 leaves from each
plantlet in aseptic conditions in a laminar ﬂow hood but without dis-
turbing plant's root system. Leaf samples of all plantlets from a single
mother plant were pooled for virus testing by real-time PCR [28]. The
traceability procedures ensured that any plantlets found to contain
virus at this stage could be linked back to the original mother plant and
all other associated cultured plantlets derived from that same mother
plant. In our project, these tests were done using real-time PCR (which
has higher sensitivity) than the end-point PCR protocols [25,26] but did
not detect CMBs or CBSIs from any tissue-cultured plants. This con-
ﬁrmed that the approach that we have used for cleaning cassava from
CMBs and CBSIs has worked. Such plantlets were certiﬁed to be virus-
free and shipped to the project partner Genetic Technologies Interna-
tional Limited (GTIL) in Kenya. The GTIL further multiplied the plants
in their tissue culture facilities and distributed to project partners in
Kenya, Tanzania, Malawi, Mozambique and Uganda [20].
Hardening is an important process in establishing tissue-cultured
plants. Complete loss of plants can occur if proper care is not taken
during the hardening process. At this stage, plantlets are highly sus-
ceptible to infections by fungi, attack by root insects, low humidity and
high temperatures. Consequently, the plantlets should be kept in a
clean, pest-free environment and provided with enough water to
maintain humidity but not so much water that plants rot. Fertilisers
should only be applied after plants are well established. The process
from initial transplanting to complete hardening takes about 8–10
weeks depending on the cassava variety and speciﬁc growth conditions.
Plants develop quicker in warmer temperatures (30–35 °C) and bright
long days. However, temperatures exceeding 40 °C such as in poly-
houses can severely hinder plant growth or result in plant death. Good
care of the plants was therefore taken which resulted on average >
90% plant survival after planting into the soil.
An important but often neglected aspect of a virus cleaning and
indexing system is traceability of the plants. As each plant is propa-
gated, PCR tested, cleaned of viruses, and multiplied to hundreds of
plantlets, it is essential to check for viruses, if any, manifested in sub-
sequent steps. If an infection is discovered, any plants linked to the
infected plant could then easily be re-tested, cleaned, or removed
without having to discard a larger batch of plants. During this project,
we employed a relatively simple but encompassing traceability system
using commonly available software such as the Microsoft's Excel
workbooks. This system allowed us to manage more than 5000 plants
through phases I to IV and ensured that we generated and shipped only
certiﬁed clean material of known origins to our project partners in
eastern and southern Africa. It is important to remember that a trace-
ability system is only as good as the data that is put into it, so it is vital
that all data input into the system are accurate. Correct labelling and
tagging of all material can minimise mistakes. We used the automated
labelling systems to reduce human error that can occur when writing
hundreds of labels by hand. Finally, we suggest that if the data in a
traceability database is discovered to be incorrectly entered, all the
material in that run should be destroyed, and the data should be se-
parated from the main documents to avoid the risk of miscategorising
material. In summary, we have demonstrated that it is possible to clean
the vegetatively-propagated crops such as cassava from two major virus
infections for germplasm exchange at the regional level. This can serve
as an example for cleaning and exchange of germplasm of other vege-
tatively-propagated crops such as bananas, potatoes, sweetpotatoes,
sugarcane and others.
5. Conclusions
In this multi-country collaborative project, we developed a method
for successfully cleaning 31 resistant/tolerant cassava varieties from
infections of CMBs and CBSIs. Plants were taken from the areas of
eastern and southern Africa that are most aﬀected by CMD and CBSD:
Kenya, Malawi, Mozambique, Tanzania and Uganda, and represented
the most promising virus-resistant varieties of cassava in each country.
This work has allowed the exchange of best cassava germplasm be-
tween the worst aﬀected countries and this is contributing to control
the two most important diseases of cassava at the regional level. The
clean cassava lines are now deposited into a permanent collection at the
International Institute of Tropical Agriculture-Nigeria germplasm col-
lection centre, thus making them available for many generations to
come as sources of disease-resistant stock.
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